National Notifiable Diseases Surveillance System, 1 January to 31 March 2015

The National Notifiable Diseases Surveillance System collates data from Australian states and territories. These data have been published on the Department of Health website and quarterly data are published in Communicable Diseases Intelligence. This page contains data for the reporting period 1 January to 31 March 2015

Page last updated: 29 July 2015

A summary of diseases currently being reported by each jurisdiction is provided in Table 1. There were 67,831 notifications to the National Notifiable Diseases Surveillance System (NNDSS) with a notification received date between 1 January to 31 March 2015 (Table 2). The notification rate of diseases per 100,000 population for each state or territory is presented in Table 3.

Table 1: Reporting of notifiable diseases by jurisdiction
Disease
 Data received from:
* Infections with Shiga-like toxin (verotoxin) producing Escherichia coli (STEC/VTEC).

NEC Not elsewhere classified.
Bloodborne diseases
Hepatitis (NEC)
 All jurisdictions
Hepatitis B (newly acquired)
 All jurisdictions
Hepatitis B (unspecified)
 All jurisdictions
Hepatitis C (newly acquired)
 All jurisdictions except Queensland
Hepatitis C (unspecified)
 All jurisdictions
Hepatitis D
 All jurisdictions
Gastrointestinal diseases
Botulism
 All jurisdictions
Campylobacteriosis
 All jurisdictions except New South Wales
Cryptosporidiosis
 All jurisdictions
Haemolytic uraemic syndrome
 All jurisdictions
Hepatitis A
 All jurisdictions
Hepatitis E
 All jurisdictions
Listeriosis
 All jurisdictions
STEC, VTEC*
 All jurisdictions
Salmonellosis
 All jurisdictions
Shigellosis
 All jurisdictions
Typhoid
 All jurisdictions
Quarantinable diseases
Cholera
 All jurisdictions
Highly pathogenic avian influenza in humans
 All jurisdictions
Plague
 All jurisdictions
Rabies
 All jurisdictions
Severe acute respiratory syndrome
 All jurisdictions
Smallpox
 All jurisdictions
Viral haemorrhagic fever
 All jurisdictions
Yellow fever
 All jurisdictions
Sexually transmissible infections
Chlamydial infection
 All jurisdictions
Donovanosis
 All jurisdictions
Gonococcal infection
 All jurisdictions
Syphilis - congenital
 All jurisdictions
Syphilis <2 years duration
 All jurisdictions
Syphilis >2 years or unspecified duration
 All jurisdictions
Vaccine preventable diseases
Diphtheria
 All jurisdictions
Haemophilus influenzae type b
 All jurisdictions
Influenza (laboratory confirmed)
 All jurisdictions
Measles
 All jurisdictions
Mumps
 All jurisdictions
Pertussis
 All jurisdictions
Pneumococcal disease (invasive)
 All jurisdictions
Poliomyelitis
 All jurisdictions
Rubella
 All jurisdictions
Rubella - congenital
 All jurisdictions
Tetanus
 All jurisdictions
Varicella zoster (chickenpox)
 All jurisdictions except New South Wales
Varicella zoster (shingles)
 All jurisdictions except New South Wales
Varicella zoster (unspecified)
 All jurisdictions except New South Wales
Vectorborne diseases
Barmah Forest virus infection
 All jurisdictions
Chikungunya virus infection
 All jurisdictions
Dengue virus infection
 All jurisdictions
Flavivirus infection (NEC)
 All jurisdictions
Japanese encephalitis virus infection
 All jurisdictions
Kunjin virus infection
 All jurisdictions
Malaria
 All jurisdictions
Murray Valley encephalitis virus infection
 All jurisdictions
Ross River virus infection
 All jurisdictions
Zoonoses
Anthrax
 All jurisdictions
Australian bat lyssavirus
 All jurisdictions
Brucellosis
 All jurisdictions
Leptospirosis
 All jurisdictions
Lyssavirus (NEC)
 All jurisdictions
Ornithosis
 All jurisdictions
Q fever
 All jurisdictions
Tularaemia
 All jurisdictions
Other bacterial infections
Legionellosis
 All jurisdictions
Leprosy
 All jurisdictions
Meningococcal infection
 All jurisdictions
Tuberculosis
 All jurisdictions

Top of page

Table 2: Notifications of diseases received by state and territory health authorities, 1 January to 31 March 2015, by date of diagnosis*
  State or territory Total 1st quarter 2015 Total 4th quarter 2014 Total 1st quarter 2014 Last 5 years mean 1st quarter Ratio Year to date 2015 Last 5 years YTD mean
Disease ACT NSW NT Qld SA Tas Vic WA
* The date of diagnosis is the onset date or where the date of onset was not known, the earliest of the specimen collection date, the notification date, or the notification receive date. For hepatitis B (unspecified), hepatitis C (unspecified), leprosy, syphilis (> 2 years or unspecified duration) and tuberculosis, the public health unit notification receive date was used.

† Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis. Queensland reports hepatitis C newly acquired under hepatitis   unspecified.

‡ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined or is greater than 24 months.

§ Infection with Shiga toxin/verotoxin-producing Escherichia coli.

|| Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral and throat samples, except for South Australia, which reports only cervical, urine and urethral specimens. From 1 July 2013 case definition changed to exclude all ocular infections.

¶ The national case definitions for chlamydial, gonococcal and syphilis diagnoses include infections that may be acquired through a non-sexual mode (especially in children – e.g. perinatal infections, epidemic gonococcal conjunctivitis).

** In the Australian Capital Territory, Murray Valley encephalitis virus infection and Kunjin virus infection are combined under Murray Valley encephalitis virus infection.

†† Only invasive meningococcal disease is nationally notifiable. However, New South Wales and the Australian Capital Territory also report conjunctival cases.

NN Not notifiable

NEC Not elsewhere classified

Totals comprise data from all states and territories. Cumulative figures are subject to retrospective revision so there may be discrepancies between the number of new notifications and the increment in the cumulative figure from the previous period.
Bloodborne diseases
Hepatitis (NEC)
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Hepatitis B (newly acquired)†
0
8
2
11
0
0
10
9
40
34
58
56.0
0.7
40
56.0
Hepatitis B (unspecified)‡
18
584
51
255
90
6
454
134
1,592
1,517
1,613
1,628.2
1.0
1,592
1,628.2
Hepatitis C (newly acquired)†
3
2
0
0
17
4
39
37
102
86
107
112.0
0.9
102
112.0
Hepatitis C (unspecified)‡
51
889
50
660
107
49
546
251
2,603
2,472
2,481
2,511.6
1.0
2,603
2,511.6
Hepatitis D
0
3
0
3
2
0
3
0
11
15
13
11.2
1.0
11
11.2
Gastrointestinal diseases
Botulism
0
1
0
0
0
0
0
0
1
0
0
0.4
2.5
1
0.4
Campylobacteriosis
122
NN
97
1,987
396
246
1,955
697
5,500
5,558
4,800
4,440.4
1.2
5,500
4,440.4
Cryptosporidiosis
4
398
27
595
160
0
209
111
1,504
455
859
1,039.6
1.4
1,504
1,039.6
Haemolytic uraemic syndrome
0
2
0
0
0
0
2
0
4
2
9
5.6
0.7
4
5.6
Hepatitis A
1
38
2
20
5
0
12
10
88
51
86
68.8
1.3
88
68.8
Hepatitis E
0
2
0
0
1
1
4
2
10
12
10
13.0
0.8
10
13.0
Listeriosis
0
8
1
3
1
0
2
1
16
20
22
25.8
0.6
16
25.8
STEC, VTEC§
0
8
0
10
6
0
3
0
27
19
40
34.0
0.8
27
34.0
Salmonellosis
92
1,589
139
2,519
409
99
1,054
556
6,457
4,113
5,206
4,416.4
1.5
6,457
4,416.4
Shigellosis
0
53
52
51
26
1
108
44
335
278
306
193.0
1.7
335
193.0
Typhoid
0
13
0
11
2
0
13
4
43
28
46
51.6
0.8
43
51.6
Quarantinable diseases
Cholera
0
0
0
0
0
0
0
0
0
0
1
0.4
0.0
0
0.4
Highly pathogenic avian influenza in humans
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Plague
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Rabies
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Severe acute respiratory syndrome
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Smallpox
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Viral haemorrhagic fever
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Yellow fever
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Sexually transmissible infections
Chlamydial infection||,¶
337
6,098
758
5,437
1,484
484
4,622
2,980
22,200
19,623
22,972
21,303.6
1.0
22,200
21,303.6
Donovanosis
0
0
0
0
0
0
0
0
0
0
1
0.2
0.0
0
0.2
Gonococcal infection
42
1,453
515
823
219
18
1,092
510
4,672
3,638
4,267
3,440.2
1.4
4,672
3,440.2
Syphilis – congenital
0
0
0
0
0
0
0
0
0
1
0
1.2
0.0
0
1.2
Syphilis < 2 years duration
3
125
38
128
17
7
231
27
576
491
452
383.4
1.5
576
383.4
Syphilis > 2 years or unspecified duration‡,¶
4
124
41
70
31
6
187
20
483
452
478
367.8
1.3
483
367.8
Vaccine preventable diseases
Diphtheria
0
0
0
1
0
0
0
0
1
1
0
0.2
5.0
1
0.2
Haemophilus influenzae type b
0
0
1
1
0
0
0
0
2
5
3
2.8
0.7
2
2.8
Influenza (laboratory confirmed)
84
1,082
38
1,377
756
38
667
515
4,557
5,719
3,834
2,111.6
2.2
4,557
2,111.6
Measles
1
4
0
7
1
0
12
2
27
36
175
57.4
0.5
27
57.4
Mumps
1
13
0
13
18
3
3
8
59
40
63
46.2
1.3
59
46.2
Pertussis
87
1,621
13
316
164
4
1,491
374
4,070
4,115
2,339
5,912.2
0.7
4,070
5,912.2
Pneumococcal disease (invasive)
1
50
12
30
16
4
56
19
188
337
216
219.6
0.9
188
219.6
Poliomyelitis
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Rubella
0
3
0
2
0
0
0
0
5
5
6
11.6
0.4
5
11.6
Rubella – congenital
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Tetanus
0
0
0
0
0
0
0
0
0
2
1
1.4
0.0
0
1.4
Varicella zoster (chickenpox)
15
NN
16
46
121
23
219
89
529
548
497
388.8
1.4
529
388.8
Varicella zoster (shingles)
40
NN
92
15
592
65
418
367
1,589
1,379
1,398
1,099.4
1.4
1,589
1,099.4
Varicella zoster (unspecified)
28
NN
1
1,498
37
28
1,159
360
3,111
3,099
3,033
2,365.2
1.3
3,111
2,365.2
Vectorborne diseases
Barmah Forest virus infection
2
73
12
168
0
0
6
9
270
97
331
699.8
0.4
270
699.8
Chikungunya virus infection
0
18
3
12
0
0
17
6
56
48
21
18.2
3.1
56
18.2
Dengue virus infection
8
121
22
147
33
3
118
283
735
255
658
475.0
1.5
735
475.0
Flavivirus infection (NEC)
0
1
0
6
0
0
0
0
7
3
14
5.4
1.3
7
5.4
Japanese encephalitis virus infection
0
1
0
0
0
0
1
0
2
0
0
0.2
10.0
2
0.2
Kunjin virus infection**
0
0
0
0
0
0
0
0
0
0
0
0.2
0.0
0
0.2
Malaria
2
12
2
19
0
1
14
13
63
61
92
104.4
0.6
63
104.4
Murray Valley encephalitis virus infection**
0
0
1
0
0
0
0
0
1
0
0
1.8
0.6
1
1.8
Ross River virus infection
7
894
179
4,062
53
2
137
388
5,722
1,485
1,616
1,987.4
2.9
5,722
1,987.4
Zoonoses
Anthrax
0
0
0
0
0
0
0
0
0
0
0
0.2
0.0
0
0.2
Australian bat lyssavirus
0
0
0
0
0
0
0
0
0
0
0
0.2
0.0
0
0.2
Brucellosis
0
2
0
0
0
0
0
0
2
3
6
6.8
0.3
2
6.8
Leptospirosis
1
4
0
12
0
2
1
0
20
11
26
46.0
0.4
20
46.0
Lyssavirus (NEC)
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Ornithosis
0
0
0
0
0
0
1
0
1
14
11
12.8
0.1
1
12.8
Q fever
0
54
1
82
5
0
7
1
150
105
125
101.2
1.5
150
101.2
Tularaemia
0
0
0
0
0
0
0
0
0
0
0
0.3
0.0
0
0.3
Other bacterial infections
Legionellosis
2
26
2
19
5
1
14
23
92
110
88
86.2
1.1
92
86.2
Leprosy
0
0
0
0
0
0
0
0
0
2
3
1.4
0.0
0
1.4
Meningococcal infection††
1
6
0
6
1
0
10
3
27
45
25
40.0
0.7
27
40.0
Tuberculosis
5
89
6
41
19
4
80
37
281
363
313
317.8
0.9
281
317.8
Total
962
15,472
2,174
20,463
4,794
1,099
14,977
7,890
67,831
56,753
58,721
67,831

Top of page

Table 3: Notification rates of diseases, 1 January to 31 March 2015, by state or territory. (Annualised rate per 100,000 population)*,†
Disease State or territory Aust
ACT NSW NT Qld SA Tas Vic WA
* The date of diagnosis is the onset date or where the date of onset was not known, the earliest of the specimen collection date, the notification date, or the notification receive date. For hepatitis B (unspecified), hepatitis C (unspecified), leprosy, syphilis (> 2 years or unspecified duration) and tuberculosis, the public health unit notification receive date was used.

† Rate per 100,000 of population. Annualisation Factor was 4.0

‡ Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis. Queensland reports hepatitis C newly acquired under hepatitis C unspecified.

§ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined or is greater than 24 months.

|| Infection with Shiga toxin/verotoxin-producing Escherichia coli.

¶ Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral and throat samples, except for South Australia, which reports only cervical, urine and urethral specimens. From 1 July 2013 case definition changed to exclude all ocular infections.

** The national case definitions for chlamydial, gonococcal and syphilis diagnoses include infections that may be acquired through a non-sexual mode (especially in children – e.g. perinatal infections, epidemic gonococcal conjunctivitis).

†† In the Australian Capital Territory, Murray Valley encephalitis virus infection and Kunjin virus infection are combined under Murray Valley encephalitis virus infection.

‡‡ Only invasive meningococcal disease is nationally notifiable. However, New South Wales and the Australian Capital Territory also report conjunctival cases.

NEC Not elsewhere classified.

NN Not notifiable.
Bloodborne diseases
Hepatitis (NEC)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Hepatitis B (newly acquired)‡
0.0
0.4
3.3
0.9
0.0
0.0
0.7
1.4
0.7
Hepatitis B (unspecified)§
18.5
31.5
84.0
21.5
21.6
4.7
31.4
20.5
27.3
Hepatitis C (newly acquired)‡
3.1
0.1
0.0
0.0
4.1
3.2
2.7
5.7
1.7
Hepatitis C (unspecified)§
52.5
48.1
82.4
55.7
25.7
38.7
37.7
38.4
44.6
Hepatitis D
0.0
0.2
0.0
0.3
0.5
0.0
0.2
0.0
0.2
Gastrointestinal diseases
Botulism
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Campylobacteriosis
125.7
NN
159.9
167.6
95.0
194.4
135.1
106.8
137.9
Cryptosporidiosis
4.1
21.5
44.5
50.2
38.4
0.0
14.4
17.0
25.8
Haemolytic uraemic syndrome
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.1
Hepatitis A
1.0
2.1
3.3
1.7
1.2
0.0
0.8
1.5
1.5
Hepatitis E
0.0
0.1
0.0
0.0
0.2
0.8
0.3
0.3
0.2
Listeriosis
0.0
0.4
1.6
0.3
0.2
0.0
0.1
0.2
0.3
STEC,VTEC||
0.0
0.4
0.0
0.8
1.4
0.0
0.2
0.0
0.5
Salmonellosis
94.8
85.8
229.1
212.5
98.1
78.2
72.8
85.2
110.6
Shigellosis
0.0
2.9
85.7
4.3
6.2
0.8
7.5
6.7
5.7
Typhoid fever
0.0
0.7
0.0
0.9
0.5
0.0
0.9
0.6
0.7
Quarantinable diseases
Cholera
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Human pathogenic avian influenza in humans
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Plague
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Rabies
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Severe acute respiratory syndrome
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Smallpox
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Viral haemorrhagic fever
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Yellow fever
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Sexually transmitted infections
Chlamydial infection¶,**
347.1
329.3
1,249.2
458.8
356.1
382.5
319.4
456.5
380.2
Donovanosis
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Gonococcal infection**
43.3
78.5
848.7
69.4
52.5
14.2
75.5
78.1
80.0
Syphilis – congenital
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Syphilis < 2 years duration**
3.1
6.7
62.6
10.8
4.1
5.5
16.0
4.1
9.9
Syphilis > 2 years or unspecified duration§,**
4.1
6.7
67.6
5.9
7.4
4.7
12.9
3.1
8.3
Vaccine preventable diseases
Diphtheria
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
Haemophilus influenzae type b
0.0
0.0
1.6
0.1
0.0
0.0
0.0
0.0
0.0
Influenza (laboratory confirmed)
80.3
58.4
62.6
116.2
181.4
30.0
46.1
78.9
77.9
Measles
1.0
0.2
0.0
0.6
0.2
0.0
0.8
0.3
0.5
Mumps
1.0
0.7
0.0
1.1
4.3
2.4
0.2
1.2
1.0
Pertussis
89.6
87.5
21.4
26.7
39.1
3.2
103.1
57.3
69.7
Pneumococcal disease (invasive)
1.0
2.7
19.8
2.5
3.8
3.2
3.9
2.9
3.2
Poliomyelitis virus infection
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Rubella
0.0
0.2
0.0
0.2
0.0
0.0
0.0
0.0
0.1
Rubella – congenital
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Tetanus
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Varicella zoster (chickenpox)
15.5
NN
26.4
3.9
28.8
18.2
15.1
13.6
13.2
Varicella zoster (shingles)
41.2
NN
151.6
1.3
142.1
51.4
28.9
56.2
39.9
Varicella zoster (unspecified)
28.8
NN
1.6
126.4
9.1
22.1
80.1
55.1
78.0
Vectorborne diseases
Barmah Forest virus infection
2.1
3.9
19.8
14.2
0.0
0.0
0.4
1.4
4.6
Chikungunya virus infection
0.0
0.9
4.9
1.0
0.0
0.0
1.2
0.9
0.9
Dengue virus infection
8.2
6.5
36.3
12.4
7.9
2.4
8.2
43.3
12.6
Flavivirus infection (NEC)
0.0
0.1
0.0
0.5
0.0
0.0
0.0
0.0
0.1
Japanese encephalitis virus infection
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
Kunjin virus infection††
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Malaria
2.1
0.6
3.3
1.6
0.0
0.8
1.0
2.0
1.1
Murray Valley encephalitis virus infection††
0.0
0.0
1.6
0.0
0.0
0.0
0.0
0.0
0.0
Ross River virus infection
7.2
48.3
295.0
342.7
12.7
1.6
9.5
59.4
98.0
Zoonoses
Anthrax
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Australia bat lyssavirus
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Brucellosis
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Leptospirosis
1.0
0.2
0.0
1.0
0.0
1.6
0.1
0.0
0.3
Lyssavirus (NEC)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Ornithosis
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
Q fever
0.0
2.9
1.6
6.9
1.2
0.0
0.5
0.2
2.6
Tularaemia
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Other bacterial diseases
Legionellosis
2.1
1.4
3.3
1.6
1.2
0.8
1.0
3.5
1.6
Leprosy
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Meningococcal infection‡‡
1.0
0.3
0.0
0.5
0.2
0.0
0.7
0.5
0.5
Tuberculosis
5.2
4.8
9.9
3.5
4.6
3.2
5.5
5.7
4.8

Top of page

In this section

CDI Search

Search Communicable Diseases Intelligence

Communicable Diseases Intelligence subscriptions

Sign-up to email updates: Subscribe Now

Communicable Diseases Surveillance